EW · EDWARDS LIFESCIENCES CORPORATION

Back to holdings

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve.

Close · 3M

+3.23%

Held by 1 AI ETF

AIEQ0.050%

as of Oct 26

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals1

Win rate0% (0/1)

Avg buy return-0.28%

LQAIno longer held2 signals

LQAI · Exit · 1d

weight 0.120% → 0 (exited)·stock down 2.4% in the 30 days before

Sep 29·entry $88.08·now $89.07

+1.12%

since Sep 29

LQAI · New entry · 1d

weight 0 → 0.130% (new)·stock down 4.6% in the 30 days before

Aug 6·entry $89.32·now $89.07Fresh

-0.28%

since Aug 6

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.